Chronic Liver Disease: New Targets and Mechanisms

Pharmacy

Chronic liver disease (CLD) is a major global health concern, characterized by persistent liver inflammation, fibrosis, and progressive dysfunction. Despite advancements in understanding the pathophysiology of liver diseases, the therapeutic options remain limited. Recent research has uncovered novel molecular pathways, signaling networks, and cellular mechanisms involved in the progression of CLD, offering potential new therapeutic targets. These mechanisms include immune dysregulation, hepatic stellate cell activation, alterations in gut-liver axis, and the role of non-coding RNAs in disease progression. Additionally, emerging targets such as fibrosis biomarkers, inflammatory cytokines, and cellular senescence pathways provide exciting opportunities for early intervention and personalized treatment strategies. This review highlights the latest discoveries in chronic liver disease research, emphasizing innovative molecular targets, their therapeutic potential, and the challenges in translating these findings into clinical practice. Understanding these mechanisms could pave the way for novel treatments that effectively halt or reverse the progression of chronic liver disease, ultimately improving patient outcomes and quality of life.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.